[ORGANIZATION]
New York University Langone Health
Featured in 2 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
246 clusters · 894 sources · last updated
Latest: Medical experts propose management system for GLP-1 obesity drugs
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
Lifestyle and dementia risk research
20 clusters · 69 sources · last updated
Latest: Lifestyle and biological research offer new insights into aging and dementia prevention
Research continues to link lifestyle habits with reduced risks of cardiovascular disease, obesity, and cognitive decline. Studies from King’s College London indicate that dietary modifications for individuals aged 40 to